BIOCRYST PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 72.34 million shares for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2015-05-08
- BIOCRYST PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2015-03-31 was 72.34M shares, a 21.40% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2014-03-31 was 59.59M shares.
- BIOCRYST PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2014 was 66.77M shares, a 20.93% increase from fiscal 2013.
- BIOCRYST PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 55.22M shares, a 11.61% increase from fiscal 2012.
- BIOCRYST PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2012 was 49.47M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|
| 2015-03-31 | 72.34M shares 10-Q · filed 2015-05-08 | |
| 2014-12-31 | 66.77M shares 10-K · filed 2015-03-02 | |
| 2014-03-31 | 59.59M shares 10-Q · filed 2015-05-08 | |
| 2013-12-31 | 55.22M shares 10-K · filed 2015-03-02 | |
| 2012-12-31 | 49.47M shares 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |